Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Seraskeris, S; Lazou, A
   alpha(1)-adrenergic stimulation mediates Ca2+-dependent inositol phosphateformation through the alpha(1B)-like adrenoceptor subtype in adult rat cardiac myocytes
   JOURNAL OF CELLULAR BIOCHEMISTRY
   
   S. Seraskeris e A. Lazou, "alpha(1)-adrenergic stimulation mediates Ca2+-dependent inositol phosphateformation through the alpha(1B)-like adrenoceptor subtype in adult rat cardiac myocytes", J CELL BIOC, 84(1), 2002, pp. 201-210
2. Nakajima, A; Nakajima, F; Shimizu, S; Ogasawara, A; Wanaka, A; Moriya, H; Einhorn, TA; Yamazaki, M
   Spatial and temporal gene expression for fibroblast growth factor type I receptor (FGFR1) during fracture healing in the rat
   BONE
   
   A. Nakajima et al., "Spatial and temporal gene expression for fibroblast growth factor type I receptor (FGFR1) during fracture healing in the rat", BONE, 29(5), 2001, pp. 458-466
3. Swami, S; Sarabia, SF; Diamandis, A; Mistry, J; Khosravi, J; Feldman, D
   A new enzyme-linked immunosorbant assay for the measurement of human vitamin D receptor
   BONE
   
   S. Swami et al., "A new enzyme-linked immunosorbant assay for the measurement of human vitamin D receptor", BONE, 28(3), 2001, pp. 319-326
4. Youngren, JF; Paik, J; Barnard, RJ
   Impaired insulin-receptor autophosphorylation is an early defect in fat-fed, insulin-resistant rats
   JOURNAL OF APPLIED PHYSIOLOGY
   
   J.F. Youngren et al., "Impaired insulin-receptor autophosphorylation is an early defect in fat-fed, insulin-resistant rats", J APP PHYSL, 91(5), 2001, pp. 2240-2247
5. Liu, YY; Ju, G; Wong-Riley, MTT
   Distribution and colocalization of neurotransmitters and receptors in the pre-Botzinger complex of rats
   JOURNAL OF APPLIED PHYSIOLOGY
   
   Y.Y. Liu et al., "Distribution and colocalization of neurotransmitters and receptors in the pre-Botzinger complex of rats", J APP PHYSL, 91(3), 2001, pp. 1387-1395
6. Lincoln, TM; Dey, N; Sellak, H
   Signal transduction in smooth muscle - Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression
   JOURNAL OF APPLIED PHYSIOLOGY
   
   T.M. Lincoln et al., "Signal transduction in smooth muscle - Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression", J APP PHYSL, 91(3), 2001, pp. 1421-1430
7. Osman, AA; Hancock, J; Hunt, DG; Ivy, JL; Mandarino, LJ
   Exercise training increases ERK2 activity in skeletal muscle of obese Zucker rats
   JOURNAL OF APPLIED PHYSIOLOGY
   
   A.A. Osman et al., "Exercise training increases ERK2 activity in skeletal muscle of obese Zucker rats", J APP PHYSL, 90(2), 2001, pp. 454-460
8. Liu, YY; Wong-Riley, MTT
   Developmental study of cytochrome oxidase activity in the brain stem respiratory nuclei of postnatal rats
   JOURNAL OF APPLIED PHYSIOLOGY
   
   Y.Y. Liu e M.T.T. Wong-Riley, "Developmental study of cytochrome oxidase activity in the brain stem respiratory nuclei of postnatal rats", J APP PHYSL, 90(2), 2001, pp. 685-694
9. Funk, JL
   A role for parathyroid hormone-related protein in the pathogenesis of inflammatory/autoimmune diseases
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   J.L. Funk, "A role for parathyroid hormone-related protein in the pathogenesis of inflammatory/autoimmune diseases", INT IMMUNO, 1(6), 2001, pp. 1101-1121
10. Dan, Q; Trinh, H; Williams, CC; Lloyd, C; Wepsic, HT; Jeffes, EWB; Jadus, MR
    Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factor
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    Q. Dan et al., "Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factor", INT IMMUNO, 1(4), 2001, pp. 737-748
11. Nijmeijer, R; Lagrand, WK; Visser, CA; Meijer, CJLM; Niessen, HWM; Hack, CE
    CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    R. Nijmeijer et al., "CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?", INT IMMUNO, 1(3), 2001, pp. 403-414
12. Lagneux, C; Lebrin, F; Demenge, P; Godin-Ribuot, D; Ribuot, C
    MAP-kinase dependent activation of kinin B1 receptor gene transcription after heat stress in rat vascular smooth muscle cells
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    C. Lagneux et al., "MAP-kinase dependent activation of kinin B1 receptor gene transcription after heat stress in rat vascular smooth muscle cells", INT IMMUNO, 1(3), 2001, pp. 533-538
13. Funakoshi, M; Sonoda, Y; Tago, K; Tominaga, S; Kasahara, T
    Differential involvement of p38 mitogen-activated protein kinase and phosphatidyl inositol 3-kinase in the IL-1-mediated NF-kappa B and AP-1 activation
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    M. Funakoshi et al., "Differential involvement of p38 mitogen-activated protein kinase and phosphatidyl inositol 3-kinase in the IL-1-mediated NF-kappa B and AP-1 activation", INT IMMUNO, 1(3), 2001, pp. 595-604
14. Cheng, JT; Liu, IM; Kuo, DH; Lin, MT
    Stimulatory effect of phenylephrine on the secretion of beta-endorphin from rat adrenal medulla in vitro
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
    
    J.T. Cheng et al., "Stimulatory effect of phenylephrine on the secretion of beta-endorphin from rat adrenal medulla in vitro", AUTON NEURO, 93(1-2), 2001, pp. 31-35
15. Liu, IM; Tsai, CC; Lai, TY; Cheng, JT
    Stimulatory effect of isoferulic acid on alpha(1A)-adrenoceptor to increase glucose uptake into cultured myoblast C2C12 cell of mice
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
    
    I.M. Liu et al., "Stimulatory effect of isoferulic acid on alpha(1A)-adrenoceptor to increase glucose uptake into cultured myoblast C2C12 cell of mice", AUTON NEURO, 88(3), 2001, pp. 175-180
16. Liu, IM; Lai, TY; Tsai, CC; Cheng, JT
    Characterization of adenosine A(1) receptor in cultured myoblast C2C12 cells of mice
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
    
    I.M. Liu et al., "Characterization of adenosine A(1) receptor in cultured myoblast C2C12 cells of mice", AUTON NEURO, 87(1), 2001, pp. 59-64
17. Abdel-Latif, AA
    Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis,protein kinases, and contraction in smooth muscle
    EXPERIMENTAL BIOLOGY AND MEDICINE
    
    A.A. Abdel-Latif, "Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis,protein kinases, and contraction in smooth muscle", EXP BIOL ME, 226(3), 2001, pp. 153-163
18. Knight, GE; Burnstock, G
    Identification of P1 and P2 purinoceptors in the aorta of the lizard (Agama sp.)
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
    
    G.E. Knight e G. Burnstock, "Identification of P1 and P2 purinoceptors in the aorta of the lizard (Agama sp.)", COMP BIOC C, 128(3), 2001, pp. 413-423
19. Jacobson, KA; Ravi, RG; Nandanan, E; Kim, HS; Moro, S; Kim, YC; Lee, K; Barak, D; Marquez, VE; Ji, XD
    Ribose modified nucleosides and nucleotides as ligands for purine receptors
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    
    K.A. Jacobson et al., "Ribose modified nucleosides and nucleotides as ligands for purine receptors", NUCLEOS NUC, 20(4-7), 2001, pp. 333-341
20. Levine, SM; Stone, JH
    New approaches to treatment in systemic vasculitis: biological therapies
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    S.M. Levine e J.H. Stone, "New approaches to treatment in systemic vasculitis: biological therapies", BEST PR R C, 15(2), 2001, pp. 315-333
21. Bench, AJ; Cross, NCP; Huntly, BJP; Nacheva, EP; Green, AR
    Myeloproliferative disorders
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    A.J. Bench et al., "Myeloproliferative disorders", BEST P R C, 14(3), 2001, pp. 531-551
22. Gloyn, AL; McCarthy, MI
    The genetics of type 2 diabetes
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    
    A.L. Gloyn e M.I. McCarthy, "The genetics of type 2 diabetes", BEST PRAC R, 15(3), 2001, pp. 293-308
23. Gonzalez, ML; Waxman, FJ
    Relationship between complement activation and renal deposition of immune complexes made with IgG2a monoclonal antibodies
    CLINICAL IMMUNOLOGY
    
    M.L. Gonzalez e F.J. Waxman, "Relationship between complement activation and renal deposition of immune complexes made with IgG2a monoclonal antibodies", CLIN IMMUNO, 100(3), 2001, pp. 362-371
24. Bhol, KC; Desai, A; Kumari, S; Colon, JE; Ahmed, AR
    Pemphigus vulgaris: The role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production
    CLINICAL IMMUNOLOGY
    
    K.C. Bhol et al., "Pemphigus vulgaris: The role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production", CLIN IMMUNO, 100(2), 2001, pp. 172-180
25. Ishizuka, T; Miura, A; Kajita, K; Ishizawa, M; Kimura, M; Huang, Y; Kawai, Y; Morita, H; Uno, Y; Yasuda, K
    Differential effect of PKC isoform on insulin- and phorbol ester-stimulated glucose uptake mechanism in rat adipocytes
    IUBMB LIFE
    
    T. Ishizuka et al., "Differential effect of PKC isoform on insulin- and phorbol ester-stimulated glucose uptake mechanism in rat adipocytes", IUBMB LIFE, 51(5), 2001, pp. 299-304
26. Shashkin, PN; Wasner, HK; Ortmeyer, HK; Hansen, BC
    Prostaglandylinositol cyclic phosphate (cPIP): a novel second messenger ofinsulin action. Comparative analysis of two kinds of 'insulin mediators'
    DIABETES-METABOLISM RESEARCH AND REVIEWS
    
    P.N. Shashkin et al., "Prostaglandylinositol cyclic phosphate (cPIP): a novel second messenger ofinsulin action. Comparative analysis of two kinds of 'insulin mediators'", DIABET M R, 17(4), 2001, pp. 273-284
27. Sone, H; Suzuki, H; Takahashi, A; Yamada, N
    Disease model: hyperinsulinemia and insulin resistance - Part A - targeteddisruption of insulin signaling or glucose transport
    TRENDS IN MOLECULAR MEDICINE
    
    H. Sone et al., "Disease model: hyperinsulinemia and insulin resistance - Part A - targeteddisruption of insulin signaling or glucose transport", TRENDS MO M, 7(7), 2001, pp. 320-322
28. Okada, S; Kopchick, JJ
    Biological effects of growth hormone and its antagonist
    TRENDS IN MOLECULAR MEDICINE
    
    S. Okada e J.J. Kopchick, "Biological effects of growth hormone and its antagonist", TRENDS MO M, 7(3), 2001, pp. 126-132
29. Mantovani, A; Locati, M; Vecchi, A; Sozzani, S; Allavena, P
    Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines
    TRENDS IN IMMUNOLOGY
    
    A. Mantovani et al., "Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines", TRENDS IMMU, 22(6), 2001, pp. 328-336
30. Dunn, E; Sims, JE; Nicklin, MJH; O'Neill, LAJ
    Annotating genes with potential roles in the immune system: six new members of them IL-1 family
    TRENDS IN IMMUNOLOGY
    
    E. Dunn et al., "Annotating genes with potential roles in the immune system: six new members of them IL-1 family", TRENDS IMMU, 22(10), 2001, pp. 533-536
31. Goldring, MB
    Anticytokine therapy for osteoarthritis
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    M.B. Goldring, "Anticytokine therapy for osteoarthritis", EXPERT OP B, 1(5), 2001, pp. 817-829
32. Phillips, MI
    Gene therapy for hypertension: sense and antisense strategies
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    M.I. Phillips, "Gene therapy for hypertension: sense and antisense strategies", EXPERT OP B, 1(4), 2001, pp. 655-662
33. Clark, WM; Lutsep, HL
    Potential of anticytokine therapies in central nervous system ischaemia
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    W.M. Clark e H.L. Lutsep, "Potential of anticytokine therapies in central nervous system ischaemia", EXPERT OP B, 1(2), 2001, pp. 227-237
34. Freeman, BD; Buchman, TG
    Interleukin-1 receptor antagonist as therapy for inflammatory disorders
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    B.D. Freeman e T.G. Buchman, "Interleukin-1 receptor antagonist as therapy for inflammatory disorders", EXPERT OP B, 1(2), 2001, pp. 301-308
35. Kimbrell, DA; Beutler, B
    The evolution and genetics of innate immunity
    NATURE REVIEWS GENETICS
    
    D.A. Kimbrell e B. Beutler, "The evolution and genetics of innate immunity", NAT REV GEN, 2(4), 2001, pp. 256-267
36. Wong, ML; Licinio, J
    Research and treatment approaches to depression
    NATURE REVIEWS NEUROSCIENCE
    
    M.L. Wong e J. Licinio, "Research and treatment approaches to depression", NAT REV NEU, 2(5), 2001, pp. 343-351
37. Allan, SM; Rothwell, NJ
    Cytokines and acute neurodegeneration
    NATURE REVIEWS NEUROSCIENCE
    
    S.M. Allan e N.J. Rothwell, "Cytokines and acute neurodegeneration", NAT REV NEU, 2(10), 2001, pp. 734-744
38. Rees, J
    Post-genome integrative biology: so that's what they call clinical science
    CLINICAL MEDICINE
    
    J. Rees, "Post-genome integrative biology: so that's what they call clinical science", CLIN MED, 1(5), 2001, pp. 393-400
39. Kelly, RW; King, AE; Critchley, HOD
    Cytokine control in human endometrium
    REPRODUCTION
    
    R.W. Kelly et al., "Cytokine control in human endometrium", REPRODUCT, 121(1), 2001, pp. 3-19
40. Smith, SK
    Angiogenesis and reproduction
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    
    S.K. Smith, "Angiogenesis and reproduction", BR J OBST G, 108(8), 2001, pp. 777-783
41. Labrador, JP; Azcoitia, V; Tuckermann, J; Lin, C; Olaso, E; Manes, S; Bruckner, K; Georgen, JL; Lemke, G; Yancopoulos, G; Angel, P; Martinez, C; Klein, R
    The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism
    EMBO REPORTS
    
    J.P. Labrador et al., "The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism", EMBO REP, 2(5), 2001, pp. 446-452
42. Reid, MB; Li, YP
    Tumor necrosis factor-alpha and muscle wasting: a cellular perspective
    RESPIRATORY RESEARCH
    
    M.B. Reid e Y.P. Li, "Tumor necrosis factor-alpha and muscle wasting: a cellular perspective", RESPIR RES, 2(5), 2001, pp. 269-272
43. Lambrecht, BN
    Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation
    RESPIRATORY RESEARCH
    
    B.N. Lambrecht, "Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation", RESPIR RES, 2(3), 2001, pp. 133-138
44. Brennan, FM
    A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" byWim B van den Berg
    ARTHRITIS RESEARCH
    
    F.M. Brennan, "A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" byWim B van den Berg", ARTHRITIS R, 3(4), 2001, pp. 211-213
45. Rehman, Q; Lane, NE
    Bone loss - Therapeutic approaches for preventing bone loss in inflammatory arthritis
    ARTHRITIS RESEARCH
    
    Q. Rehman e N.E. Lane, "Bone loss - Therapeutic approaches for preventing bone loss in inflammatory arthritis", ARTHRITIS R, 3(4), 2001, pp. 221-227
46. Del Vecchio, MA; Georgescu, HI; McCormack, JE; Robbins, PD; Evans, CH
    Approaches to enhancing the retroviral transduction of human synoviocytes
    ARTHRITIS RESEARCH
    
    M.A. Del Vecchio et al., "Approaches to enhancing the retroviral transduction of human synoviocytes", ARTHRITIS R, 3(4), 2001, pp. 259-263
47. van den Berg, WB
    Anti-cytokine therapy in chronic destructive arthritis
    ARTHRITIS RESEARCH
    
    W.B. van den Berg, "Anti-cytokine therapy in chronic destructive arthritis", ARTHRITIS R, 3(1), 2001, pp. 18-26
48. Ferri, KF; Kroemer, G
    Organelle-specific initiation of cell death pathways
    NATURE CELL BIOLOGY
    
    K.F. Ferri e G. Kroemer, "Organelle-specific initiation of cell death pathways", NAT CELL BI, 3(11), 2001, pp. E255-E263
49. Schwinn, DA
    The role of alpha(1)-adrenergic receptor subtypes in lower urinary tract symptoms
    BJU INTERNATIONAL
    
    D.A. Schwinn, "The role of alpha(1)-adrenergic receptor subtypes in lower urinary tract symptoms", BJU INT, 88, 2001, pp. 27-34
50. Dong, Q; Ginsberg, HN; Erlanger, BF
    Overexpression of the A(1) adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance
    DIABETES OBESITY & METABOLISM
    
    Q. Dong et al., "Overexpression of the A(1) adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance", DIABET OB M, 3(5), 2001, pp. 360-366
51. Smith, MD; Slavotinek, J; Au, V; Weedon, H; Parker, A; Coleman, M; Roberts-Thomson, PJ; Ahern, MJ
    Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression
    RHEUMATOLOGY
    
    M.D. Smith et al., "Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression", RHEUMATOLOG, 40(9), 2001, pp. 965-977
52. Gotoh, M; Hamada, K; Yamakawa, H; Yanagisawa, K; Nakamura, M; Yamazaki, H; Ueyama, Y; Tamaoki, N; Inoue, A; Fukuda, H
    Interleukin-1-induced subacromial synovitis and shoulder pain in rotator cuff diseases
    RHEUMATOLOGY
    
    M. Gotoh et al., "Interleukin-1-induced subacromial synovitis and shoulder pain in rotator cuff diseases", RHEUMATOLOG, 40(9), 2001, pp. 995-1001
53. Hulkkonen, J; Pertovaara, M; Antonen, J; Pasternack, A; Hurme, M
    Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease
    RHEUMATOLOGY
    
    J. Hulkkonen et al., "Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease", RHEUMATOLOG, 40(6), 2001, pp. 656-661
54. Roux-Lombard, P; Eberhardt, K; Saxne, T; Dayer, JM; Wollheim, FA
    Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation inearly rheumatoid arthritis. A prospective 5-year study
    RHEUMATOLOGY
    
    P. Roux-Lombard et al., "Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation inearly rheumatoid arthritis. A prospective 5-year study", RHEUMATOLOG, 40(5), 2001, pp. 544-551
55. Cunnane, G; Madigan, A; Murphy, E; FitzGerald, O; Bresnihan, B
    The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis
    RHEUMATOLOGY
    
    G. Cunnane et al., "The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis", RHEUMATOLOG, 40(1), 2001, pp. 62-69
56. Xue, ML; Willcox, MDP; Lloyd, A; Wakefield, D; Thakur, A
    Regulatory role of IL-1 beta in the expression of IL-6 and IL-8 in human corneal epithelial cells during Pseudomonas aeruginosa colonization
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    
    M.L. Xue et al., "Regulatory role of IL-1 beta in the expression of IL-6 and IL-8 in human corneal epithelial cells during Pseudomonas aeruginosa colonization", CLIN EXP OP, 29(3), 2001, pp. 171-174
57. Nakazawa, I; Nakajima, T; Harada, H; Ishigami, T; Umemura, S; Emi, M
    Human calcitonin receptor-like receptor for adrenomedullin: genomic structure, eight single-nucleotide polymorphisms, and haplotype analysis
    JOURNAL OF HUMAN GENETICS
    
    I. Nakazawa et al., "Human calcitonin receptor-like receptor for adrenomedullin: genomic structure, eight single-nucleotide polymorphisms, and haplotype analysis", J HUM GENET, 46(3), 2001, pp. 132-136
58. Iwasa, H; Kurabayashi, M; Nagai, R; Nakamura, Y; Tanaka, T
    Multiple single-nucleotide polymorphisms (SNPs) in the Japanese populationin six candidate genes for long QT syndrome
    JOURNAL OF HUMAN GENETICS
    
    H. Iwasa et al., "Multiple single-nucleotide polymorphisms (SNPs) in the Japanese populationin six candidate genes for long QT syndrome", J HUM GENET, 46(3), 2001, pp. 158-162
59. Kacena, MA; Merrel, GA; Konda, SR; Wilson, KM; Xi, YG; Horowitz, MC
    Inflammation and bony changes at the temporomandibular joint
    CELLS TISSUES ORGANS
    
    M.A. Kacena et al., "Inflammation and bony changes at the temporomandibular joint", CELLS T ORG, 169(3), 2001, pp. 257-264
60. Tarkowski, E; Liljeroth, AM; Nilsson, A; Minthon, L; Blennow, K
    Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    E. Tarkowski et al., "Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease", DEMENT G C, 12(5), 2001, pp. 314-317
61. Filler, G; Yang, F; Martin, A; Stolpe, J; Neumayer, HH; Hocher, B
    Renin angiotensin system gene polymorphisms in pediatric renal transplant recipients
    PEDIATRIC TRANSPLANTATION
    
    G. Filler et al., "Renin angiotensin system gene polymorphisms in pediatric renal transplant recipients", PEDIAT TRAN, 5(3), 2001, pp. 166-173
62. Elliott, JT; Hoekstra, WJ; Derian, CK; Ahern, DG; Addo, MF; Maryanoff, BE; Prestwich, GD
    Tritiated photoactivatable analogs of the native human thrombin receptor (PAR-1) agonist peptide, SFLLRN-NH2
    JOURNAL OF PEPTIDE RESEARCH
    
    J.T. Elliott et al., "Tritiated photoactivatable analogs of the native human thrombin receptor (PAR-1) agonist peptide, SFLLRN-NH2", J PEPT RES, 57(6), 2001, pp. 494-506
63. Balla, T
    Pharmacology of phosphoinositides, regulators of multiple cellular functions
    CURRENT PHARMACEUTICAL DESIGN
    
    T. Balla, "Pharmacology of phosphoinositides, regulators of multiple cellular functions", CUR PHARM D, 7(6), 2001, pp. 475-507
64. Alvarez, D; Wiley, RE; Jordana, M
    Cytokine therapeutics for asthma: An appraisal of current evidence and future prospects
    CURRENT PHARMACEUTICAL DESIGN
    
    D. Alvarez et al., "Cytokine therapeutics for asthma: An appraisal of current evidence and future prospects", CUR PHARM D, 7(11), 2001, pp. 1059-1081
65. Valentinis, B; Baserga, R
    IGF-I receptor signalling in transformation and differentiation
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    
    B. Valentinis e R. Baserga, "IGF-I receptor signalling in transformation and differentiation", J CL PATH-M, 54(3), 2001, pp. 133-137
66. Dupont, J; Le Roith, D
    Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    
    J. Dupont e D. Le Roith, "Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects", J CL PATH-M, 54(3), 2001, pp. 149-154
67. Bigonnesse, F; Marois, M; Maheux, R; Akoum, A
    Interleukin-1 receptor accessory protein is constitutively expressed in human endometrium throughout the menstrual cycle
    MOLECULAR HUMAN REPRODUCTION
    
    F. Bigonnesse et al., "Interleukin-1 receptor accessory protein is constitutively expressed in human endometrium throughout the menstrual cycle", MOL HUM REP, 7(4), 2001, pp. 333-339
68. Gabay, C
    Gene therapy: will it deliver for RA?
    DRUG DISCOVERY TODAY
    
    C. Gabay, "Gene therapy: will it deliver for RA?", DRUG DISC T, 6(7), 2001, pp. 343-344
69. McGill, JB
    Angiotensin II receptor antagonist plus a thiazide diuretic is more efficacious for treating hypertension than either drug alone
    BLOOD PRESSURE MONITORING
    
    J.B. McGill, "Angiotensin II receptor antagonist plus a thiazide diuretic is more efficacious for treating hypertension than either drug alone", BL PRESS M, 6, 2001, pp. S3-S13
70. Littlejohn, TW
    Clinical considerations in hypertensive black patients: the role of angiotensin II receptor blockers in combination with a diuretic
    BLOOD PRESSURE MONITORING
    
    T.W. Littlejohn, "Clinical considerations in hypertensive black patients: the role of angiotensin II receptor blockers in combination with a diuretic", BL PRESS M, 6, 2001, pp. S15-S21
71. Lacourciere, Y
    Usefulness of combination therapy in hypertensive patients who do not respond to an angiotensin type 1 receptor antagonist alone
    BLOOD PRESSURE MONITORING
    
    Y. Lacourciere, "Usefulness of combination therapy in hypertensive patients who do not respond to an angiotensin type 1 receptor antagonist alone", BL PRESS M, 6, 2001, pp. S23-S30
72. Hiroi, N; Wong, ML; Licinio, J; Park, C; Young, M; Gold, PW; Chrousos, GP; Bornstein, SR
    Expression of corticotropin releasing hormone receptors type I and type IImRNA in suicide victims and controls
    MOLECULAR PSYCHIATRY
    
    N. Hiroi et al., "Expression of corticotropin releasing hormone receptors type I and type IImRNA in suicide victims and controls", MOL PSYCHI, 6(5), 2001, pp. 540-546
73. Shibuya, M
    Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1)
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    
    M. Shibuya, "Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1)", INT J BIO C, 33(4), 2001, pp. 409-420
74. Francis, SE; Camp, NJ; Burton, AJ; Dewberry, RM; Gunn, J; Stephens-Lloyd, A; Cumberland, DC; Gershlick, A; Crossman, DC
    Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty
    HEART
    
    S.E. Francis et al., "Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty", HEART, 86(3), 2001, pp. 336-340
75. van Geel, PP; Pinto, YM; Zwinderman, AH; Henning, RH; van Boven, A; Jukema, JW; Bruschke, AVG; Kastelein, JJP; van Gilst, WH
    Increased risk for ischaemic events is related to combined RAS polymorphism
    HEART
    
    P.P. van Geel et al., "Increased risk for ischaemic events is related to combined RAS polymorphism", HEART, 85(4), 2001, pp. 458-462
76. Mata, M; Zhang, MD; Hu, XP; Fink, DJ
    HveC (nectin-1) is expressed at high levels in sensory neurons, but not inmotor neurons, of the rat peripheral nervous system
    JOURNAL OF NEUROVIROLOGY
    
    M. Mata et al., "HveC (nectin-1) is expressed at high levels in sensory neurons, but not inmotor neurons, of the rat peripheral nervous system", J NEUROVIRO, 7(5), 2001, pp. 476-480
77. Paez-Espinosa, V; Rocha, EM; Velloso, LA; Saad, MJA
    Regulation of insulin-stimulated tyrosine phosphorylation of Shc and Shc/Grb2 association in liver, muscle, and adipose tissue of epinephrine- and streptozotocin-treated rats
    ENDOCRINE
    
    V. Paez-Espinosa et al., "Regulation of insulin-stimulated tyrosine phosphorylation of Shc and Shc/Grb2 association in liver, muscle, and adipose tissue of epinephrine- and streptozotocin-treated rats", ENDOCRINE, 14(3), 2001, pp. 295-302
78. White, M; Racine, N; Ducharme, A; de Champlain, J
    Therapeutic potential of angiotensin II receptor antagonists
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    M. White et al., "Therapeutic potential of angiotensin II receptor antagonists", EXPERT OP I, 10(9), 2001, pp. 1687-1701
79. von Lubitz, DKJE
    Adenosine in the treatment of stroke: yes, maybe, or absolutely not?
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    D.K.J.E. von Lubitz, "Adenosine in the treatment of stroke: yes, maybe, or absolutely not?", EXPERT OP I, 10(4), 2001, pp. 619-632
80. Agrawal, DK
    Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    D.K. Agrawal, "Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug", EXPERT OP I, 10(3), 2001, pp. 547-560
81. Strutz, F
    Potential methods to prevent interstitial fibrosis in renal disease
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    F. Strutz, "Potential methods to prevent interstitial fibrosis in renal disease", EXPERT OP I, 10(11), 2001, pp. 1989-2001
82. Ronzoni, S; Peretto, L; Giardina, GAM
    Lead generation and lead optimisation approaches in the discovery of selective, non-peptide ORL-1 receptor agonists and antagonists
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    S. Ronzoni et al., "Lead generation and lead optimisation approaches in the discovery of selective, non-peptide ORL-1 receptor agonists and antagonists", EXPERT OP T, 11(4), 2001, pp. 525-546
83. Hess, S
    Recent advances in adenosine receptor antagonist research
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    S. Hess, "Recent advances in adenosine receptor antagonist research", EXPERT OP T, 11(10), 2001, pp. 1533-1561
84. Ferre, S; Popoli, P; Gimenez-Llort, L; Rimondini, R; Muller, CE; Stromberg, I; Ogren, O; Fuxe, K
    Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease
    PARKINSONISM & RELATED DISORDERS
    
    S. Ferre et al., "Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease", PARKINS R D, 7(3), 2001, pp. 235-241
85. Sachdev, D; Yee, D
    The IGF system and breast cancer
    ENDOCRINE-RELATED CANCER
    
    D. Sachdev e D. Yee, "The IGF system and breast cancer", ENDOCR-R CA, 8(3), 2001, pp. 197-209
86. Holtkamp, GM; Kijlstra, A; Peek, R; de Vos, AF
    Retinal pigment epithelium-immune system interactions: Cytokine productionand cytokine-induced changes
    PROGRESS IN RETINAL AND EYE RESEARCH
    
    G.M. Holtkamp et al., "Retinal pigment epithelium-immune system interactions: Cytokine productionand cytokine-induced changes", PROG RET EY, 20(1), 2001, pp. 29-48
87. Lademann, U; Kallunki, T; Jaattela, M
    A20 zinc finger protein inhibits TNF-induced apoptosis and stress responseearly in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins
    CELL DEATH AND DIFFERENTIATION
    
    U. Lademann et al., "A20 zinc finger protein inhibits TNF-induced apoptosis and stress responseearly in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins", CELL DEAT D, 8(3), 2001, pp. 265-272
88. Fumarola, C; Zerbini, A; Guidotti, GG
    Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis
    CELL DEATH AND DIFFERENTIATION
    
    C. Fumarola et al., "Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis", CELL DEAT D, 8(10), 2001, pp. 1004-1013
89. Charlesworth, JA; Peake, PW; Pussell, BA; Erlich, JH
    Complement in renal disease
    NEPHROLOGY
    
    J.A. Charlesworth et al., "Complement in renal disease", NEPHROLOGY, 6(4), 2001, pp. 145-154
90. Arora, M; Arora, R; Tiwari, SC; Das, M; Srivastava, LM
    Expression of complement regulatory proteins on erythrocytes from patientswith idiopathic focal segmental glomerulosclerosis
    NEPHROLOGY
    
    M. Arora et al., "Expression of complement regulatory proteins on erythrocytes from patientswith idiopathic focal segmental glomerulosclerosis", NEPHROLOGY, 6(1), 2001, pp. 37-41
91. Faldt, J; Dahlgren, C; Ridell, M; Karlsson, A
    Priming of human neutrophils by mycobacterial lipoarabinomannans: role of granule mobilisation
    MICROBES AND INFECTION
    
    J. Faldt et al., "Priming of human neutrophils by mycobacterial lipoarabinomannans: role of granule mobilisation", MICROBES IN, 3(13), 2001, pp. 1101-1109
92. Hughes, LB; Moreland, LW
    New therapeutic approaches to the management of rheumatoid arthritis
    BIODRUGS
    
    L.B. Hughes e L.W. Moreland, "New therapeutic approaches to the management of rheumatoid arthritis", BIODRUGS, 15(6), 2001, pp. 379-393
93. Pearce, GJ; Chikanza, IC
    Targeting tumour necrosis factor in the treatment of rheumatoid arthritis
    BIODRUGS
    
    G.J. Pearce e I.C. Chikanza, "Targeting tumour necrosis factor in the treatment of rheumatoid arthritis", BIODRUGS, 15(3), 2001, pp. 139-149
94. Krishnagopalan, S; Dellinger, RP
    Innovative therapies for sepsis
    BIODRUGS
    
    S. Krishnagopalan e R.P. Dellinger, "Innovative therapies for sepsis", BIODRUGS, 15(10), 2001, pp. 645-654
95. Taylor, KD; Yang, HY; Rotter, JI
    Inflammatory bowel disease - II. Gene mapping
    MOLECULAR GENETICS AND METABOLISM
    
    K.D. Taylor et al., "Inflammatory bowel disease - II. Gene mapping", MOL GEN MET, 74(1-2), 2001, pp. 22-44
96. Frank, SJ
    Growth hormone signalling and its regulation: Preventing too much of a good thing
    GROWTH HORMONE & IGF RESEARCH
    
    S.J. Frank, "Growth hormone signalling and its regulation: Preventing too much of a good thing", GROWTH H I, 11(4), 2001, pp. 201-212
97. Nishimura, H
    Angiotensin receptors - evolutionary overview and perspectives
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR AND INTEGRATIVE PHYSIOLOGY
    
    H. Nishimura, "Angiotensin receptors - evolutionary overview and perspectives", COMP BIOC A, 128(1), 2001, pp. 11-30
98. Sandberg, K; Ji, H
    Comparative analysis of amphibian and mammalian angiotensin receptors
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR AND INTEGRATIVE PHYSIOLOGY
    
    K. Sandberg e H. Ji, "Comparative analysis of amphibian and mammalian angiotensin receptors", COMP BIOC A, 128(1), 2001, pp. 53-75
99. Ryder, JW; Gilbert, M; Zierath, JR
    Skeletal muscle and insulin sensitivity: Pathophysiological alterations
    FRONTIERS IN BIOSCIENCE
    
    J.W. Ryder et al., "Skeletal muscle and insulin sensitivity: Pathophysiological alterations", FRONT BIOSC, 6, 2001, pp. D154-D163
100. Ogino, S; Kubo, S; Abdul-Karim, FW; Cohen, ML
     Comparative immunohistochemical study of insulin-like growth factor II andinsulin-like growth factor receptor type 1 in pediatric brain tumors
     PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
     
     S. Ogino et al., "Comparative immunohistochemical study of insulin-like growth factor II andinsulin-like growth factor receptor type 1 in pediatric brain tumors", PEDIATR D P, 4(1), 2001, pp. 23-31